MacroGenics, Inc. (MGNX)
3.47
-0.13
(-3.61%)
USD |
NASDAQ |
Apr 13, 16:00
3.48
+0.01
(+0.29%)
After-Hours: 20:00
MacroGenics Cash from Investing (TTM) : -114.10M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Amgen, Inc. | -1.943B |
| Amicus Therapeutics, Inc. | -46.43M |
| Merck & Co., Inc. | -13.74B |
| Pfizer Inc. | -1.351B |
| Xencor, Inc. | 139.98M |